Correlation Between Abcellera Biologics and Aegon NV

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Aegon NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Aegon NV into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and Aegon NV ADR, you can compare the effects of market volatilities on Abcellera Biologics and Aegon NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Aegon NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Aegon NV.

Diversification Opportunities for Abcellera Biologics and Aegon NV

0.29

Correlation Coefficient

Abcellera Biologics  Aegon NV

Modest diversification

The 3 months correlation between Abcellera and Aegon is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Aegon NV ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aegon NV ADR and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Aegon NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aegon NV ADR has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Aegon NV go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Aegon NV

Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the Aegon NV. In addition to that, Abcellera Biologics is 2.12 times more volatile than Aegon NV ADR. It trades about -0.06 of its total potential returns per unit of risk. Aegon NV ADR is currently generating about 0.04 per unit of volatility. If you would invest  449.00  in Aegon NV ADR on September 20, 2024 and sell it today you would earn a total of  134.00  from holding Aegon NV ADR or generate 29.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Abcellera Biologics  vs.  Aegon NV ADR

Abcellera Biologics

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Aegon NV ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aegon NV ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Aegon NV is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Abcellera Biologics and Aegon NV

The main advantage of trading using opposite Abcellera Biologics and Aegon NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Aegon NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aegon NV will offset losses from the drop in Aegon NV's long position.

The idea behind Abcellera Biologics and Aegon NV ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.